High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression

OncoImmunology

Volumn 4, Issue 3, 2015, Pages 1-7

  Bento, Diana Costa ^a   Jones, Emma ^a   Junaid, Syed ^a   Tull, Justyna ^b   Williams, Geraint T ^c   Godkin, Andrew ^a   Ager, Ann ^a   Gallimore, Awen ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Colorectal cancer; High endothelial venules; Lymphoid aggregates follicles; T cells; Tumor infiltrating lymphocytes and tertiary lymphoid organs

Indexed keywords

ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; HIGH ENDOTHELIAL VENULE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; VENULE;

EID: 84954518640     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.974374     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/ 10.3322/caac.20107
2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383:1490-502; PMID:24225001; http://dx.doi.org/10.1016/S0140-6736(13)61649-9
3. Dukes CE. The classification of the cancer of the rectum. J Pathol Bacteriol 1932; 35:323-32; http://dx.doi.org/10.1002/path.1700350303
4. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352:476-87; PMID: 15689586; http://dx.doi.org/10.1056/NEJMra040958
5. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID: 17008531; http://dx.doi.org/10.1126/science.1129139
6. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; PMID:16371631; http://dx.doi.org/10.1056/NEJMoa051424
7. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998;58:3491-4;PMID:9721846
8. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets ofmemory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12; PMID:10537110; http://dx.doi.org/10.1038/44385
9. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995; 16:449-57; PMID:7546210; http://dx.doi.org/10.1016/0167-5699(95)80023-9
10. Hayasaka H, Taniguchi K, Fukai S, Miyasaka M. Neogenesis and development of the high endothelial ven-ules that mediate lymphocyte trafficking. Cancer Sci 2010; 101:2302-8; PMID:20726857; http://dx.doi.org/10.1111/j.1349-7006.2010.01687.x
11. Moussion C, Girard J-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011; 479:542-6; PMID:22080953; http://dx.doi.org/10.1038/nature10540
12. Stranford S, Ruddle NH. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lymph node stroma. Front Immunol 2012; 3:350; PMID: 23230435.
13. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678-87; PMID:21846823; http://dx.doi.org/10.1158/0008-5472. CAN-11-0431
14. Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, Garrido I, Girard J-P. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. Oncoimmunology 2012; 1:829-39; PMID:23162750; http://dx.doi.org/10.4161/onci.20492
15. Avram G, Sáinchez-Sendra B, Martín JM, Terrádez L, Ramos D, Monteagudo C. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma. Histopathology 2013; 63:852-61; PMID:24102908; http://dx.doi.org/10.1111/his.12235
16. Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, Laghi L, Allavena P, Mantovani A, Marchesi F. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res 2014; 20:2147-58; PMID:24523438; http://dx.doi.org/ 10.1158/1078-0432.CCR-13-2590
17. Hindley JP, Jones E, Smart K, Bridgeman H, Lauder SN, Ondondo B, Cutting S, Ladell K, Wynn KK, Withers D et al. T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res 2012; 72:5473-82; PMID:22962270; http://dx.doi.org/10.1158/0008-5472.CAN-12-1912
18. Betts G, Jones E, Junaid S, El-Shanawany T, Scurr M, Mizen P, Kumar M, Jones S, Rees B, Williams G et al. Suppression of tumour-specific CD4C T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut 2012; 61:1163-71; PMID:22207629; http://dx.doi.org/10.1136/gutjnl-2011-300970
19. Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One 2006; 1:e129; PMID:17205133; http://dx.doi.org/10.1371/journal.pone.0000129
20. Scurr M, Ladell K, Besneux M, Christian A, Hockey T, Smart K, Bridgeman H, Hargest R, Phillips S, Davies M et al. Highly prevalent colorectal cancer-infiltrating LAP(C) Foxp3(—) T cells exhibit more potent immunosuppressive activity than Foxp3(C) regulatory T cells. Mucosal Immunol 2014; 7:428-39; PMID:24064667; http://dx.doi.org/10.1038/mi.2013.62
21. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofu-nato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Koyama Y et al. Ectopic expression of MECA-79 as a novel prognostic indicator in gastric cancer. Cancer Sci 2011; 102:1088-94; PMID:21281400; http://dx.doi.org/10.1111/j.1349-7006.2011.01895.x
22. Boland CR, Goel A. Microsatellite instability in colo-rectal cancer. Gastroenterology 2010; 138:2073-87; PMID:20420947; http://dx.doi.org/10.1053/j.gastro.2009.12.064
23. Buckowitz A, Knaebel H-P, Benner A, Blaker H, Gebert J, Kienle P, Knebel Doeberitz von M, Kloor M. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005; 92:1746-53; PMID:15856045; http://dxdoi.org/10.1038/sj.bjc.6602534
24. Nascimbeni R, Fabio FD, Betta ED, Mariani P, Fisogni S, Villanacci V. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 2005; 18:681-5; PMID:15578077, http://dx.doi.org/10.1038/modpathol.3800343
25. Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? WJG 2012; 18:3839-48; PMID:22876036; http://dx.doi.org/10.3748/wjg.v18.i29.3839
26. Vayrynen JP, Sajanti SA, Klintrup K, Makela J, Herzig K-H, Karttunen TJ, Tuomisto A, Makinen MJ. Characteristics and significance of colorectal cancer associated lymphoid reaction. Int J Cancer 2014; 134:212-635; PMID:24154855; http://dx.doi.org/10.1002/ijc.28533
27. de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, Cremer I, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Research 2011; 71:6391-9; PMID:21900403; http://dx.doi.org/10.1158/0008-5472.CAN-11-0952